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A B S T R A C T
Purpose: Fatigue impairs the quality of life (QOL) of epilepsy patients, but few studies have investigated
this issue and no systematic analysis of the predictors of fatigue in epilepsy patients has been performed.
Thus, we investigated the degree and predictors of fatigue in epilepsy patients.
Methods: We enrolled 270 consecutive adult patients with epilepsy and categorized them into three
subgroups: uncontrolled epilepsy (UCE), well-controlled epilepsy (WCE), and poorly controlled epilepsy
(PCE). All subjects were asked to complete the Korean versions of the Fatigue Severity Scale (K-FSS), the
Neurological Disorders Depression Inventory for Epilepsy (K-NDDI-E), the Generalized Anxiety Disorder-
7 (K-GAD-7) scale, and the short forms of the Patient-Reported Outcomes Measurement Information
System Sleep-Related Impairment (PROMIS-SRI) and Sleep Disturbance (PROMIS-SD) scales. Addition-
ally, 200 normal control subjects who completed the K-FSS, K-NDDI-E, and K-GAD-7 measures were
included. The K-FSS scores of the epilepsy subgroups and the control group were compared, and stepwise
multiple regression analysis was performed to identify predictors of high scores on the K-FSS among
epilepsy patients.
Results: The K-FSS, K-NDDI-E, and K-GAD-7 scores were higher in the epilepsy patients than in the
controls. The K-FSS scores of the UCE subgroup, but not of the PCE and WCE subgroups, were higher than
those of the control group. K-FSS scores of epilepsy patients were predicted by PROMIS-SRI and K-NDDI-
E scores.
Conclusions: Fatigue was more severe in epilepsy patients than in healthy controls without epilepsy,
especially when seizures were not controlled. Sleep-related impairments and depression aggravated
fatigue in epilepsy patients.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
Contents lists available at ScienceDirect
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Fatigue has been deﬁned as the experience of extreme and
persistent tiredness, weakness, or exhaustion that can be mental,
physical, or both [1]. Fatigue is associated with and may be
aggravated by neurological disorders such as multiple sclerosis,
Parkinson’s disease, and stroke [2–6]; similarly, fatigue is also a
common complaint of epilepsy patients [7–12]. The prevalence of
fatigue ranges from 35.0% to 66.7% in epilepsy patients [9–12] but
only occurs in 10–25% of the general population [7,8,13]. The
fatigue experienced by epilepsy patients is more severe than that
of healthy volunteers and the degree of fatigue in these patients is
comparable to that of patients with multiple sclerosis [1].* Correspondence ing author. Tel.: +82 53 420 5769; fax: +82 53 422 4265.
E-mail address: sppark@mail.knu.ac.kr (S.-P. Park).
http://dx.doi.org/10.1016/j.seizure.2015.12.003
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reMoreover, fatigue in epilepsy patients may precipitate their
seizures [14,15] and, for this reason, a better understanding of
fatigue in epilepsy patients is crucial to effectively manage the
course of the disease and the treatment regimen. However, only a
few studies have compared the degree of fatigue in epilepsy
patients with that of the general population and, even studies that
have assessed the propensity for fatigue in epilepsy patients, have
used relatively small numbers of patients and controls [1].
Likewise, studies investigating the predictors of fatigue in
epilepsy patients are also relatively rare. Although several studies
have shown that fatigue in epilepsy patients is related to sleep
quality, depression, and anxiety [1,12,16,17], the variables
associated with epilepsy, including seizure types, seizure freedom,
and factors related to antiepileptic drugs (AEDs), have not been
correlated with fatigue [1,16–18]. Of these studies, one [1]
observed a tendency for increased fatigue based on the number
of AEDs or the number of seizures, but without statisticalserved.
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number of epilepsy-related factors remain unclear.
Thus, the present study aimed to determine the degree and
predictors of fatigue in epilepsy patients by comparing their
characteristics with those of healthy control subjects. To accom-
plish this, a wide variety of epilepsy-related variables, including
socioeconomic factors, seizure-related features, and depression,
anxiety, and sleep-related problems were assessed to determine
the predictors of fatigue in epilepsy patients.
2. Methods
The present cross-sectional study was approved by the
Institutional Review Board of Kyungpook National University
Hospital. Upon enrollment, all subjects provided informed consent
and were asked to complete a battery of reliable and validated self-
report health questionnaires that included the Korean versions of
the Fatigue Severity Scale (K-FSS), the Neurological Disorders
Depression Inventory for Epilepsy (K-NDDI-E), the Generalized
Anxiety Disorder-7 (K-GAD-7) scale, and the short forms of the
Patient-Reported Outcomes Measurement Information System
(PROMISTM) Sleep-Related Impairment (PROMIS-SRI) and Sleep
Disturbance (PROMIS-SD) scales.
2.1. Subjects
Epilepsy patients who had been treated with AEDs for at least 1
year and who had attended the epilepsy clinic at Kyungpook
National University Hospital between July 1, 2014 and January 31,
2015 were consecutively enrolled in the present study. EpilepsyTable 1
Characteristics and questionnaire scores of eligible study subjects.
Characteristics Mean  S
Epilepsy 
Age, years 39.8  12
Gender, male 168 (62.2
Education, years 12.9  2.8
Job, yes 130 (48.1
Household income, 1 (million KRW per month) 209 (77.4
Drivers’ license, yes 162 (60.0
Married but no divorce or bereavement 123 (45.6
Concurrent medical disease 80 (29.6%
Age at onset, years 25.1  13
Duration of epilepsy, years 14.7  11
Type of seizure, partial 212 (78.5
Epilepsy syndrome
Temporal lobe epilepsy 131 (48.5
Extra-temporal lobe epilepsy 81 (30.0%
Generalized epilepsy 50 (18.5%
Unknown 8 (3.0%)
MRI, abnormal 122 (45.2
Family history of epilepsy 21 (7.8%)
History of febrile convulsions 60 (22.2%
Duration of AED intake, years 11.6  10
AED regimen, monotherapy 125 (46.3
AED load 1.3  0.9 
Seizure control
Well-controlled epilepsy 143 (53.0
Partially controlled epilepsy 78 (28.9%
Uncontrolled epilepsy 49 (18.1%
Co-administration of psychiatric drug 38 (14.1%
PROMIS-SD 48.6  10
PROMIS-SRI 48.3  9.9
K-QOLIE-10 overall score 75.5  20
a Independent t-test or Chi-square test used for analysis.
KRW: Korean won, MRI: magnetic resonance imaging, AED: antiepile
Measurement Information System-Sleep Disturbance, PROMIS-SR
Information System-Sleep-Related Impairment, K-QOLIE-10: Korean 
deviation, MRI: magnetic resonance imagingwas diagnosed according to the criteria of the International League
Against Epilepsy (ILAE) for seizures and epileptic syndromes [19].
Subjects younger than 19 years of age and older than 70 years of
age and subjects with severe neurological, psychiatric, or other
disorders that prevented them from understanding the ques-
tionnaires and fully cooperating with the study were excluded
from the ﬁnal analyses. The present study initially included 320
epilepsy patients, but 50 were excluded for the following reasons:
refusal to complete the questionnaires (n = 24), severe neurologi-
cal or other disorders (n = 19), psychosis (n = 1), being older than
70 years of age (n = 4), less than 1 year of AED treatment (n = 1),
and lack of education (n = 1). Thus, 270 epilepsy patients were
included in the ﬁnal analyses of the present study.
The demographic, socioeconomic, and clinical characteristics of
the study subjects are summarized in Table 1. The epilepsy
patients were classiﬁed into three subgroups based on the state of
their seizure control: uncontrolled epilepsy (UCE), well-controlled
epilepsy (WCE), and poorly controlled epilepsy (PCE). UCE was
deﬁned as an average of more than one seizure per month for 18
months and no seizure-free periods longer than 3 months, which
were the criteria used to determine drug-refractory epilepsy as a
failure in previous adequate trials of two AEDs [20]. WCE was
deﬁned as freedom from seizures during the preceding year, and
PCE was deﬁned as an intermediate degree of seizure control that
did not meet the criteria for UCE or WCE. Of the 270 epilepsy
patients, 49 were classiﬁed with UCE, 78 with PCE, and 143 with
WCE. The seizure-control classiﬁcation for each epilepsy patient
was determined based on information about seizure frequency
obtained from their medical records. Additionally, 200 age- and
sex-matched healthy adult volunteers were enrolled in the studyD (range) or percentage (%) p valuea
patients (n = 270) Controls (n = 200)
.4 (19–70) 40.3  12.3 (19–70) 0.677
%) 125 (62.5%) 1.000
 (6–20) 14.8  2.4 (6–20) <0.001
%) 137 (68.5%) <0.001
%) 192 (96.0%) <0.001
%) 178 (89.0%) <0.001
%) 125 (62.5%) <0.001
) 28 (14.0%) <0.001
.1 (1–63)
.0 (1–57)
%)
%)
)
)
%)
)
.0 (1–54)
%)
(0.2–4.6)
%)
)
)
)
.4 (28.9–76.5)
 (30.0–80)
.0 (7.5–100)
ptic drug, PROMIS-SD: short form of Patient-Reported Outcomes
I: short form of Patient-Reported Outcomes Measurement
version of Quality of Life in Epilepsy Inventory-10, SD: standard
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epilepsy patients and the controls subjects are summarized in
Table 1.
2.2. Study design
The electronic medical records of the enrolled patients were
reviewed to obtain information regarding patient-related variables
such as age, gender, concurrent medical diseases, and the co-
administration of psychiatric drugs; epilepsy-related variables
such as family history of epilepsy, age at onset, duration of
epilepsy, duration of AED medication use, AED regimens, drug load
of AEDs, etiology of epilepsy, seizure type, seizure freedom over the
preceding year, and febrile convulsions; and psychosocial variables
such as education, job, income, marriage, and possession of a
drivers’ license. Drug load of AED was estimated as the sum of the
ratios of ‘prescribed daily dose’ over ‘deﬁned daily dose’ for each
AED in the regimen of individual patients [21]. The ‘deﬁned daily
dose’ means the assumed average daily maintenance dose of the
AED when used for its main indication [22]. The K-NDDI-E, K-GAD-
7, K-FSS, PROMIS-SRI, PROMIS-SD, and the Quality of Life (QOL) in
Epilepsy Inventory-10 (K-QOLIE-10) scale were completed by
patients. The control subjects completed the K-NDDI-E, K-GAD-7,
and K-FSS scales.
2.3. Questionnaires
2.3.1. The K-NDDI-E
The K-NDDI-E is a quick, reliable, and validated screening tool
for major depressive disorder (MDD) in epilepsy patients [23]. This
is a six-item measure using a four-point scale (1–4) to evaluate the
degree to which an epilepsy patient has been bothered by
depression-related problems over the previous 2 weeks. The total
scores range from 6 to 24, and higher scores indicate a more
intense level of depression. A total score of 12 or more is suggestive
of MDD, and the Cronbach’s a coefﬁcient is 0.898 [23].
2.3.2. The K-GAD-7
The GAD-7 is a self-report questionnaire used for the rapid
detection of generalized anxiety disorder [24]. This is seven-item
measure uses a four-point scale (0–3) to assess the degree to which
a subject has been bothered by anxiety-related problems over the
previous 2 weeks. The total GAD-7 scores range from 0 to 21, and
higher scores indicate a more intense level of anxiety. The present
study utilized the K-GAD-7, which can be downloaded from the
Patient Health Questionnaire website [www.phqscreeners.com;
[25]. The K-GAD-7 has been validated, a total score of 7 or more in
the Korean version of the measure is suggestive of generalized
anxiety disorder, and the Cronbach’s a coefﬁcient is 0.924 [26].
2.3.3. The QOLIE-10
The QOLIE-10 is a 10-item self-administered questionnaire
speciﬁcally designed to measure QOL in patients with PCE [27].
This measure consists of subscales that address epilepsy effects,
mental health, and role functioning, and higher scores are
indicative of a better QOL. The present study utilized the K-
QOLIE-10. The Cronbach’s a coefﬁcient of the Korean version is
0.843 for the epilepsy effects and role function subscales and 0.606
for the mental health subscale [27].
2.3.4. The K-FSS
The FSS consists of nine items that assess fatigue on a scale from
0 to 7 [28]. After summing the scores of the nine items, the total
score is divided by 9, yielding values from 0 to 7. The FSS is useful in
clinical practice because it has fewer items than other ques-
tionnaires that evaluate fatigue and it is easy to score. TheCronbach’s a coefﬁcient of the Korean version of the FSS is 0.935,
and a total score of 3.22 or more is suggestive of suffering from
fatigue [29].
2.3.5. The PROMISTM and subscales
To improve the quality of the assessments of patient-reported
outcomes, a cooperative group founded by scientists from several
US-based academic institutions and the National Institutes of
Health was created. This group developed the PROMISTM item
banks, which precisely and efﬁciently measure patient-reported
symptoms in individuals with various chronic diseases and
conditions [30]. More advanced sleep-associated questionnaires
that assess two different aspects of sleep-related problems have
been developed from the PROMISTM: the PROMISTM-SRI and the
PROMISTM-SD. The full version of the PROMISTM includes 16
PROMISTM-SRI items and 27 PROMISTM-SD items, whereas the
short forms of the PROMISTM-SRI and PROMISTM-SD each has eight
items. The convergent and discriminant validities of the short
forms of PROMISTM-SD and PROMISTM-SRI reﬂect correlations with
the full versions of PROMISTM-SD and F- PROMISTM-SRI, respec-
tively [31]. The responders report the details of their sleep and
sleep-related disturbances over the last 7 days using a ﬁve-point
scale [31]; thus, total scores on the short forms of the PROMISTM-
SRI and PROMISTM-SD each range from 0 to 40. For the ﬁnal
interpretation of these questionnaires, the individual items are
summed and the corresponding t-scores are estimated from a
nonlinear transformation. The Korean version of the short forms of
PROMISTM-SRI and PROMISTM-SD were used in the present study.
2.4. Statistical analysis
The descriptive statistics, including counts, percentages, means,
and standard deviations, are summarized in Table 1. Independent
t-tests and chi-square tests were used to compare the K-FSS,
K-NDDI-E, and K-GAD-7 scores of the epilepsy patients in all the
subgroups with those of the control subjects. A one-way analysis of
variance (ANOVA) was used to compare the scores among the
study groups, and independent t-tests were used to compare each
potential pair of groups. In order to obtain the most valid and
accurate information possible, a p value <0.01 rather than <0.05
was considered to indicate statistical signiﬁcance for all compar-
isons.
To determine the relationship between K-FSS scores and each
study variable, a Pearson’s correlation coefﬁcient analysis was used
to select the variables that were correlated with these scores; a p
value <0.05 was considered to indicate statistical signiﬁcance.
Using the selected variables, a stepwise multiple regression
analysis was performed to identify the best combination of
predictors of a high K-FSS score; a p value <0.01 was considered to
indicate statistical signiﬁcance, and dummy variables were used as
the categorical variables. Because QOL is the ultimate psychosocial
reﬂection of the lives of epilepsy patients, the effect of K-QOLIE-10
scores may have obscured the results of the stepwise regression.
For this reason, K-QOLIE-10 scores were not included in the
stepwise regression analysis even though this score was signiﬁ-
cantly correlated with the K-FSS score. A collinearity statistical
analysis was also conducted as a redundancy check. SPSS software
(version 21, IBM Inc.; SPSS Inc., Chicago, IL, USA) was used for all
statistical analyses.
3. Results
3.1. Characteristics of epilepsy patients and control subjects
The demographic, socioeconomic, clinical, and psychosocial
characteristics of epilepsy patients and control subjects are
Table 3
Variables correlated with K-FSS scores in epilepsy patients.
Variable p value (r)a
Job 0.008 (0.162)
Drivers’ license 0.015 (0.148)
Married but no divorce or bereavement 0.004 (0.175)
Age at onset 0.016 (0.147)
Household income 0.019 (0.143)
AED regimen, monotherapy 0.016 (0.147)
Seizure control <0.001 (0.211)
Co-administration of psychiatric drugs <0.001 (0.283)
PROMIS-SD <0.001 (0.519)
PROMIS-SRI <0.001 (0.643)
K-QOLIE-10 <0.001 (0.546)
K-NDDI-E <0.001 (0.497)
K-GAD-7 <0.001 (0.498)
a Pearson’s correlation analysis was used for the analysis.
K-FSS: Korean version of Fatigue Severity Scale, AED: antiepileptic drug, PROMIS-
SRI: short form of Patient-Reported Outcomes Measurement Information System
Sleep-Related Impairment, PROMIS-SD: short form of Patient-Reported Outcomes
Measurement Information System Sleep-Disturbance, K-QOLIE-10: Korean version
of Quality of Life in Epilepsy Inventory-10, K-NDDI-E: Korean version of
Neurological Disorders Depression Inventory for Epilepsy, K-GAD-7: Korean
version of Generalized Anxiety Disorder-7
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subjects were matched by age and gender, there were a number of
signiﬁcant differences (p < 0.001) between the two sets of
subjects. The epilepsy patients were more likely to have concurrent
medical diseases; less likely to be married, have a job, or have a
drivers’ license; had fewer total years of total education; and had a
lower level of income.
3.2. Comparisons between epilepsy subgroups and control subjects
The K-FSS, K-NDDI-E, and K-GAD-7 scores of the epilepsy
patients, the epilepsy subgroups, and the control subjects are
shown in Table 2. There were signiﬁcant differences in the K-FSS,
K-NDDI-E, and K-GAD-7 scores between the epilepsy patients and
the controls (p < 0.01). The comparisons between each potential
pair of the three epilepsy subgroups and the control group revealed
that the K-FSS, K-NDDI-E, and K-GAD-7 scores were higher in the
UCE subgroup than in the control group and that the K-NDDI-E
scores were higher in the PCE subgroup than in the control group
(p < 0.01 for all comparisons). The comparisons of each potential
pair among the three epilepsy subgroups revealed that the K-FSS,
K-NDDI-E, and K-GAD-7 scores were higher in the UCE subgroup
than in the WCE subgroup (p < 0.01).
3.3. Pearson’s correlation coefﬁcients for the relationship between K-
FSS scores and each study variable
The study variables that were signiﬁcantly correlated with the
K-FSS scores are listed in Table 3. The K-FSS scores were higher in
the following subgroups of epilepsy patients: those with no job, a
low household income, no driver’s license, who were unmarried,
who had an early age of onset, who had no seizure freedom, who
were undergoing a polytherapy, and who were undergoing the co-
administration of psychiatric drugs. The K-FSS scores were also
higher in epilepsy patients with high PROMIS-SRI, PROMIS-SD, K-
NDDI-E, and K-GAD-7 scores and in epilepsy patients with low
total K-QOLIE-10 scores. However, the duration of AED medication
use and drug load of AEDs were not associated with KFSS scores.
3.4. Predictors of the K-FSS score
The stepwise multiple regression analysis in the present study
produced a model with two variables that explained 44.9% of the
variance. The strongest predictors of K-FSS scores were PROMIS-
SRI (b = 0.526, p < 0.01) and K-NDDI-E (b = 0.232, p < 0.01;
Table 4) scores. The standardized b value revealed that the effect
of PROMIS-SRI scores on K-FSS scores were 2.27 times stronger
than that of K-NDDI-E scores. Because the redundancy check
showed that the variance inﬂation factors were less than 10 for theTable 2
Fatigue, depression, and anxiety in epilepsy patients compared with control subjects.
M
Total patients with epilepsy (n = 270) UCE (n = 49) 
K-FSS 3.1  1.5 (1.0–7.0)b 3.8  1.6 (1.1–6.7)b,**
K-NDDI-E 10.1  4.5 (6–24)b 12.5  5.7 (6–24)b,**
K-GAD-7 4.7  5.4 (0–21)b 7.6  6.2 (0–21)b,**
a p < 0.05, Comparisons with controls.
b p < 0.01, Comparisons with controls.
* p < 0.05, Comparison with WCE.
** p < 0.01, Comparison with WCE.
A one-way ANOVA was used for the comparisons of the scores of WCE, PCE, and UCE p
compare the scores between the epilepsy patients and control subjects and between each
uncontrolled epilepsy, PCE: poorly controlled epilepsy, WCE: well-controlled epileps
Neurological Disorders Depression Inventory for Epilepsy, K-GAD-7: Korean version oftwo signiﬁcant variables, their effects were independent of each
other.
4. Discussion
The present study demonstrated that the fatigue experienced
by epilepsy patients was more severe than that experienced by the
healthy control subjects. A previous study found that the severity
of fatigue is higher in epilepsy patients than in healthy controls
but the numbers of subjects in each group in that study were
relatively small [1]. The present study included 270 epilepsy
patients and 200 healthy control subjects, which is a greater
number of participants than included in other studies investigat-
ing fatigue in epilepsy patients [1,16,17]. This may render the
differences in fatigue observed in epilepsy patients and controls in
the present study more reliable and valid. Additionally, the
present study also compared the degree of fatigue of each epilepsy
subgroup with age- and sex-matched control subjects. The K-FSS
scores of the UCE subgroup, but not of the PCE or WCE subgroups,
were signiﬁcantly higher than those of the control group. The
present study also assessed numerous variables describing
various characteristics of the subjects, including socioeconomic
and seizure-related variables, depression, anxiety, and sleep-
related problems, to identify the predictors of fatigue more
accurately. The results show that the fatigue in epilepsy patientsean  SD (range)
PCE (n = 78) WCE (n = 143) Controls (n = 200)
3.1  1.4 (1.0–6.7) 2.9  1.4 (1.0–7.0) 2.7  1.3 (1.0–6.6)
10.2  4.4 (6–24)b 9.2  3.8 (6–24) 8.7  2.9 (1–18)
5.3  5.9 (0–21)a,* 3.4  4.2 (0–21) 3.5  3.6 (0–19)
atients with those of the control subjects. Independent t-tests were performed to
 potential pair of the three subgroups of epilepsy patients and control subjects. UCE:
y, K-FSS: Korean version of Fatigue Severity Scale, K-NDDI-E: Korean version of
 Generalized Anxiety Disorder-7, SD: standard deviation
Table 4
Predictors of K-FSS scores in epilepsy patients according to a multiple stepwise
regression analysis.
Variable Standardized
coefﬁcients (ß)
p value Collinearity
(VIF)
Adjusted
R2
0.449
PROMIS-SRI 0.526 <0.001 1.340
K-NDDI-E 0.232 <0.001 1.340
K-FSS: Korean version of Fatigue Severity Score, PROMIS-SRI: short form of Patient-
Reported Outcomes Measurement Information System Sleep-Related Impairment,
K-NDDI-E: Korean version of Neurological Disorders Depression Inventory for
Epilepsy, VIF: variance inﬂation factor
O.-Y. Kwon, S.-P. Park / Seizure 34 (2016) 48–5352was primarily associated with sleep-related impairments and
depression.
Two previous studies found that sleep-related problems are
crucial predictors of fatigue in epilepsy patients, but the particular
aspects of the sleep-related problems differ among studies. Neves
et al. [16] included sleep quality and daytime sleepiness as
candidate variables in their analysis and found that sleep quality,
but not daytime sleepiness, was a signiﬁcant predictor of fatigue in
epilepsy patients. In contrast, Hamelin et al. [17] found that
daytime sleepiness was an important predictor of fatigue in
epilepsy patients, although this study did not include sleep quality
as a candidate predictor. The present study utilized advanced
forms of questionnaires to evaluate sleep quality and daytime
sleepiness: the PROMIS-SD and PROMIS-SRI, respectively. PROMIS-
SRI scores were signiﬁcant predictors of fatigue in epilepsy
patients, but PROMIS-SD scores were not, which is concordant
with the ﬁndings of Hamelin et al. [17].
Epilepsy and depression have a bidirectional relationship and,
as a corollary of this relationship, depression is often comorbid
with epilepsy. It has been found that 9–37% of epilepsy patients
suffer from depression [32], and several studies have shown that
fatigue in epilepsy patients is determined by the presence of
depression [9,16]. Neves et al. [16] determined that depression and
sleep quality are signiﬁcant predictors of fatigue in epilepsy
patients and that the effects of depression are stronger than those
of sleep quality. In the present study, sleep-related impairments,
but not sleep quality, was a signiﬁcant predictor of fatigue, and this
effect was 2.27 times stronger than that of depression.
The present study compared the degrees of fatigue between
each potential pair of the three epilepsy subgroups and the control
group and found that K-FSS scores were signiﬁcantly higher in the
UCE subgroup than in the control group. However, the K-FSS scores
of the PCE and WCE subgroups did not differ from that of the
control group. These ﬁndings suggest that fatigue may be more
severe in epilepsy patients when their seizures are not controlled.
On the other hand, the stepwise multiple regression analysis in theTable 5
Differences in sleep-related problems among the epilepsy subgroup
UCE (n = 49) PCE
PROMIS-SDa 51.86  11.05 (28.90–76.50)** 49.3
PROMIS-SRIb 53.39  10.27 (30.00–76.90)** 49.2
A one-way ANOVA was conducted for the comparisons of the score
performed to compare the scores between each potential pair of the th
epilepsy, PCE: poorly controlled epilepsy, PROMIS-SD: short form of
Sleep Disturbance, PROMIS-SRI: short form of Patient-Reported
Impairment, SD: standard deviation
a p < 0.05, Comparison among all three subgroups.
b p < 0.01, Comparison among all three subgroups.
* p < 0.05, Comparison with WCE.
** p < 0.01, Comparison with WCE.present study showed that seizure control was not a signiﬁcant
predictor of fatigue in epilepsy patients.
No correlations between fatigue and epilepsy-related variables,
including seizure type, seizure freedom, and factors associated
with AED treatment, have been observed in previous studies [1,16–
18]. Of these studies, one observed that the number of AEDs and
the number of seizures tended to increase fatigue, but these
relationships did not exhibit statistical signiﬁcance [1]. To date,
only one study has found a high frequency of seizures to be a
signiﬁcant predictor of fatigue in epilepsy patients, but the study
did not include psychosocial factors or sleep-related problems in
the multiple regression analysis [12].
There is a vicious cycle between sleep-related problems and
seizure control. Seizures are likely a primary cause of sleep-
related problems, and sleep-related problems may aggravate
seizure control states [33–35]. A few studies have investigated
seizure precipitants in epilepsy patients, and these found that
fatigue and sleep deprivation tended to precipitate seizures
[14,15]. Thus, it is impossible to ignore the association between
fatigue and seizure control in epilepsy patients. In the context of
these ﬁndings, our observation suggests important associations
among fatigue, sleep-related problems, and seizure control. This
study found a partial relationship among these variables; the
stepwise regression analysis showed that K-FSS scores were
determined by PROMIS scores and that K-FSS scores were higher
in UCE patients but not in WCE patients compared with control
subjects (Table 2). Furthermore, PROMIS-SRI scores were higher
in the UCE subgroup than in the WCE subgroup (Table 5). These
ﬁndings may be interpreted to mean that fatigue has an indirect
relationship with seizure control. Although seizure control per se
may not directly be involved with the experience of fatigue, the
seizure control state may inﬂuence the fatigue of epilepsy patients
via indirect mechanisms that are mediated by sleep-related
impairments.
Patients with UCE are more likely to be given additional AEDs
than are those with WCE and patients who receive more AEDs may
be associated with greater levels of fatigue than those given lesser
amounts of AEDs [1]. This association was also evident in the
correlation analysis in the present study; in which the K-FSS
scores were higher in the epilepsy patients who underwent
polytherapy than in those who underwent monotherapy. AED
loads were not correlated with K-FSS scores and, despite the
relationship between K-FSS scores and drug number, K-FSS scores
were not predicted by drug number. This suggests that the drug
number may also have indirect effects on fatigue by inﬂuencing
sleep-related impairments, in a similar way to the effects of
seizure control on fatigue.
As observed in this and previous studies [9,16,17], sleep-related
problems and depression may intensify fatigue in epilepsy
patients. Thus, screening for depression and sleep-relateds according to seizure control in epilepsy patients.
Mean  SD (range)
 (n = 78) WCE (n = 143)
4  10.06 (28.90–76.50) 47.01  10.01 (28.90–76.50)
2  9.56 (30.00–73.30)* 46.07  9.33 (30.00–80.00)
s among WCE, PCE, and UCE patients. Independent t-tests were
ree subgroups. UCE: uncontrolled epilepsy, WCE: well-controlled
 Patient-Reported Outcomes Measurement Information System-
 Outcomes Measurement Information System Sleep-Related
O.-Y. Kwon, S.-P. Park / Seizure 34 (2016) 48–53 53problems should be conducted in epilepsy patients to prevent
fatigue. The present results also indicate that fatigue in epilepsy
patients may be more severe than fatigue in healthy people when
the seizures of the patients are not controlled and, therefore,
fatigue levels must be considered when seizure control is an issue.
The fatigue of epilepsy patients may be reduced by improving sleep
hygiene and treating depression and, more speciﬁcally, the present
study showed that the fatigue of UCE patients may be ameliorated
by improving seizure control. Conversely, the reduction of fatigue
may also aid in the control of seizures. Sleep-related problems,
depression, and fatigue have been shown to impair QOL in epilepsy
patients [9,33,36,37]; thus, it is possible that reducing fatigue and
depression and improving sleep hygiene and seizure control may
lead to enhanced QOL in epilepsy patients.
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